跳至主要内容
临床试验/EUCTR2015-003177-14-ES
EUCTR2015-003177-14-ES进行中(未招募)1 期

Paracetamol versus ibuprofen in preterm infants with a hemodynamically significant patent ductus arteriosus: a randomized clinical trial.

未提供0 个研究点开始时间: 2016年4月20日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • ? Informed consent signed by parents or legal representative.
  • ? Gestational age ? 30 weeks.
  • ? Postnatal age ? 2 weeks
  • ? 1st episode of hemodynamically significant PDA diagnosed by ultrasound:
  • 1. Continuous flow through DAP.
  • 2. Retrograde diastolic flow in the descending aorta.
  • 3. Strain the left atrium. (relationship left atrium / aorta (LA / AO)> 1.5).
  • 4. Ductal diameter greater than 1.7 mm.
  • 5. Relationship ductus / descending aorta diameter size greater than 0.5.
  • ? Need for ventilatory support
  • ? Born in participating hospitals or coming to them in the application of the treatment period
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 396
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - Gestational age> 30 weeks
  • - Postnatal age> 2 weeks
  • - Major congenital malformations.
  • - Impending doom.
  • - Chromosomopaties.
  • - Refusal to participate and / or sign the informed consent.
  • - Inability to randomization or scrambling wrong.
  • - Participation in another clinical trial
  • - Diuresis less than 1 ml / kg / h for 8 h prior to treatment
  • - Greater than 1.8 mg / dl Creatinine
  • - Platelets below 50,000 / uL
  • - Active bleeding (tracheal, gastrointestinal and renal)
  • - Intraventricular hemorrhage recently (48h) (grades 3-4)
  • - Severe hyperbilirubinemia
  • - Liver failure or severe coagulopathy
  • - Active necrotizing enterocolitis or intestinal perforation
  • - Septic shock

研究者

发起方
未提供

相似试验